Characterizing the Drug Development Pipeline for Precision Medicines

Amitabh Chandra, Craig Garthwaite and Ariel Dora Stern

A chapter in Economic Dimensions of Personalized and Precision Medicine, 2018, pp 115-157 from National Bureau of Economic Research, Inc

JEL-codes: I1 L5 O3 (search for similar items in EconPapers)
Date: 2018
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (2)

Downloads: (external link)
http://www.nber.org/chapters/c13994.pdf (application/pdf)

Related works:
Working Paper: Characterizing the Drug Development Pipeline for Precision Medicines (2017)
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nbr:nberch:13994

Ordering information: This item can be ordered from
http://www.nber.org/chapters/c13994

Access Statistics for this chapter

More chapters in NBER Chapters from National Bureau of Economic Research, Inc National Bureau of Economic Research, 1050 Massachusetts Avenue Cambridge, MA 02138, U.S.A.. Contact information at EDIRC.
Bibliographic data for series maintained by ().